Kevin Kunzmann

The collaboration intends to combine AbbVie’s clinical resources in monoclonal antibody develop with Voyager’s gene therapy platform.

Mesenchymal stem cell transplantation showed long-lasting and consistent effects on opioid tolerance and opioid-induced hyperalgesia in rat and mouse models.

The retinal injection therapy could be capable of replacing damaged cells integral to eye vision.

Luxturna, an injection therapy, helped genetic vision-loss patients navigate mazes in a phase 3 trial.

An advisory committee gave unanimous support to Luxturna, 3 months prior to its BLA ruling.

The Sanford Project: T-Rex Study has reached its midway point through a Phase II, fast-tracked trial.